| Literature DB >> 28948378 |
Minoo Shahidi1,2, Mousa Vatanmakanian3, Masoumeh Kourosh Arami4, Fatemeh Sadeghi Shirazi5, Najibeh Esmaeili5, Samaneh Hydarporian5, Soudeh Jafari6.
Abstract
Platelet-rich plasma (PRP) has been established as an autologous source for therapeutic angiogenesis. The purpose of this study was to evaluate PRP angiogenic effects compared to platelet-poor plasma (PPP) in vitro and in vivo. The effects of PRP on vascular endothelial growth factor receptor-2 (VEGFR2) and CD34 expression were evaluated using real-time PCR, flow cytometry, western blot, immunocytochemistry and pathological study, as were carried out in both human umbilical endothelial cell culture and rat skin. Our findings indicated significant effect of PRP and PPP on VEGFR2 and CD34 expression by human umbilical vein endothelial cells, which was greater in latter. These effects, however, were confirmed by demonstrating an earlier angiogenic effect of PPP in vivo when compared to PRP. The findings of the present study as the first comparative study of PRP versus PPP are novel. Nevertheless, further studies are needed to clarify the underlying mechanism of these findings to improve the therapeutic effects of PRP and PPP.Entities:
Keywords: Angiogenesis; Human umbilical vein endothelial cells; Platelet-poor plasma; Platelet-rich plasma
Mesh：
Substances：
Year: 2017 PMID： 28948378 DOI： 10.1007/s00795-017-0168-5
Source DB: PubMed Journal: Med Mol Morphol ISSN： 1860-1499 Impact factor: 2.309